Quick Heal Technologies Limited (NSE:QUICKHEAL)
India · Delayed Price · Currency is INR 175.61
-3.15 (-1.76%)
At close: Feb 13, 2026
Quick Heal Technologies Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
| 2,774 | 2,795 | 2,918 | 2,781 | 3,419 | 3,330 | |
Revenue Growth (YoY) | -5.77% | -4.19% | 4.91% | -18.66% | 2.66% | 16.39% |
Cost of Revenue | 80.6 | 96.8 | 97.8 | 122.2 | 150.8 | 148.2 |
Gross Profit | 2,694 | 2,699 | 2,820 | 2,659 | 3,268 | 3,182 |
Selling, General & Admin | 2,075 | 2,074 | 1,893 | 1,906 | 1,687 | 1,389 |
Other Operating Expenses | 648.8 | 636 | 696.9 | 691.2 | 502.8 | 342.4 |
Operating Expenses | 2,859 | 2,839 | 2,716 | 2,757 | 2,364 | 1,961 |
Operating Income | -165 | -140.6 | 104.1 | -98.2 | 904.2 | 1,221 |
Interest Expense | -2.3 | -2.2 | -1.3 | - | - | - |
Interest & Investment Income | 7.8 | 7.8 | 12.9 | 17.8 | 29 | 71.3 |
Currency Exchange Gain (Loss) | 1 | 1 | -1.5 | -7.1 | - | -1.5 |
Other Non Operating Income (Expenses) | 47.2 | 8.1 | 8 | 27.4 | 35.5 | 49.8 |
EBT Excluding Unusual Items | -111.3 | -125.9 | 122.2 | -60.1 | 968.7 | 1,341 |
Gain (Loss) on Sale of Investments | 134.6 | 134.6 | 122.5 | 100.8 | 102.5 | 120.1 |
Gain (Loss) on Sale of Assets | 1.3 | 1.3 | 2.7 | 39.5 | 16.5 | 0.4 |
Asset Writedown | - | - | -3.2 | - | -0.9 | - |
Pretax Income | 24.6 | 10 | 262.1 | 80.2 | 1,087 | 1,461 |
Income Tax Expense | -33 | -40.4 | 19.7 | 16.2 | 254.9 | 391.6 |
Net Income | 57.6 | 50.4 | 242.4 | 64 | 831.9 | 1,070 |
Net Income to Common | 57.6 | 50.4 | 242.4 | 64 | 831.9 | 1,070 |
Net Income Growth | -74.20% | -79.21% | 278.75% | -92.31% | -22.23% | 43.76% |
Shares Outstanding (Basic) | 55 | 54 | 53 | 56 | 59 | 64 |
Shares Outstanding (Diluted) | 56 | 55 | 54 | 56 | 60 | 64 |
Shares Change (YoY) | 1.29% | 2.00% | -3.64% | -6.04% | -7.10% | -2.05% |
EPS (Basic) | 1.05 | 0.94 | 4.56 | 1.14 | 14.01 | 16.66 |
EPS (Diluted) | 1.03 | 0.91 | 4.48 | 1.14 | 13.94 | 16.65 |
EPS Growth | -74.61% | -79.69% | 292.98% | -91.82% | -16.28% | 46.83% |
Free Cash Flow | - | -367.2 | 106.3 | 267.3 | 741.3 | 897.6 |
Free Cash Flow Per Share | - | -6.66 | 1.97 | 4.77 | 12.42 | 13.97 |
Dividend Per Share | - | - | 3.000 | 2.500 | 4.500 | 4.000 |
Dividend Growth | - | - | 20.00% | -44.44% | 12.50% | - |
Gross Margin | 97.09% | 96.54% | 96.65% | 95.61% | 95.59% | 95.55% |
Operating Margin | -5.95% | -5.03% | 3.57% | -3.53% | 26.45% | 36.67% |
Profit Margin | 2.08% | 1.80% | 8.31% | 2.30% | 24.33% | 32.12% |
Free Cash Flow Margin | - | -13.14% | 3.64% | 9.61% | 21.68% | 26.95% |
EBITDA | -42.63 | -24 | 213 | 25.7 | 1,045 | 1,360 |
EBITDA Margin | -1.54% | -0.86% | 7.30% | 0.92% | 30.57% | 40.84% |
D&A For EBITDA | 122.38 | 116.6 | 108.9 | 123.9 | 141 | 138.8 |
EBIT | -165 | -140.6 | 104.1 | -98.2 | 904.2 | 1,221 |
EBIT Margin | -5.95% | -5.03% | 3.57% | -3.53% | 26.45% | 36.67% |
Effective Tax Rate | - | - | 7.52% | 20.20% | 23.45% | 26.80% |
Revenue as Reported | 3,021 | 3,003 | 3,131 | 3,002 | 3,611 | 3,572 |
Advertising Expenses | - | 202 | 187.5 | 343 | 276.8 | 226.2 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.